CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation
暂无分享，去创建一个
T. Curiel | O. Boyman | Anand V. R. Kornepati | Chenghao Zhang | R. Svatek | J. Conejo-Garcia | Niannian Ji | Yilun Deng | Chen Zhang | K. Wheeler | Neelam Mukherjee | Á. Padrón | H. Gupta | Deyi Zhang | Ryan M. Reyes | Aravind Kancharla | Myrna G Garcia | A. Kornepati | A. Padron | R. Reyes